These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34135000)

  • 1. An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer.
    Sharif GM; Campbell MJ; Nasir A; Sengupta S; Graham GT; Kushner MH; Kietzman WB; Schmidt MO; Pearson GW; Loudig O; Fineberg S; Wellstein A; Riegel AT
    Cancer Res; 2021 Aug; 81(16):4230-4241. PubMed ID: 34135000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer.
    Saenz FR; Ory V; Schmidt MO; Kallakury BV; Mueller SC; Furth PA; Wellstein A; Riegel AT
    Neoplasia; 2019 Oct; 21(10):963-973. PubMed ID: 31437536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
    Ory V; Kietzman WB; Boeckelman J; Kallakury BV; Wellstein A; Furth PA; Riegel AT
    Breast Cancer Res Treat; 2018 May; 169(1):47-57. PubMed ID: 29350308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.
    Ory V; Tassi E; Cavalli LR; Sharif GM; Saenz F; Baker T; Schmidt MO; Mueller SC; Furth PA; Wellstein A; Riegel AT
    Oncogene; 2014 Jun; 33(23):3033-42. PubMed ID: 23851504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
    Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
    Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
    Kushner MH; Ory V; Graham GT; Sharif GM; Kietzman WB; Thevissen S; Yuan M; Schmidt MO; Wellstein A; Riegel AT
    EMBO Rep; 2020 Jan; 21(1):e48741. PubMed ID: 31788936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling.
    Mo P; Zhou Q; Guan L; Wang Y; Wang W; Miao M; Tong Z; Li M; Majaz S; Liu Y; Su G; Xu J; Yu C
    Oncogene; 2015 Jul; 34(30):3935-3945. PubMed ID: 25263446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells.
    Vella V; Giuliano M; La Ferlita A; Pellegrino M; Gaudenzi G; Alaimo S; Massimino M; Pulvirenti A; Dicitore A; Vigneri P; Vitale G; Malaguarnera R; Morrione A; Sims AH; Ferro A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 12. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.
    Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA
    Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.
    Serizawa M; Murakami H; Watanabe M; Takahashi T; Yamamoto N; Koh Y
    Cancer Sci; 2014 Jun; 105(6):683-9. PubMed ID: 24698130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cathepsin S expression by HSP90 and 5-HT
    Gautam J; Bae YK; Kim JA
    Breast Cancer Res Treat; 2017 Jan; 161(1):29-40. PubMed ID: 27796714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion.
    Westcott JM; Prechtl AM; Maine EA; Dang TT; Esparza MA; Sun H; Zhou Y; Xie Y; Pearson GW
    J Clin Invest; 2015 May; 125(5):1927-43. PubMed ID: 25844900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.